Related references
Note: Only part of the references are listed.RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Discovery and Development of Therapeutic Aptamers
P. R. Bouchard et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate
Kitae Park et al.
BIOMATERIALS (2010)
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Hee Dong Han et al.
CLINICAL CANCER RESEARCH (2010)
A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides
Sara Trabulo et al.
JOURNAL OF CONTROLLED RELEASE (2010)
A Nucleolin-Targeted Multimodal Nanoparticle Imaging Probe for Tracking Cancer Cells Using an Aptamer
Do Won Hwang et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Toxicity Pathway Focused Gene Expression Profiling of PEI-Based Polymers for Pulmonary Applications
Andrea Beyerle et al.
MOLECULAR PHARMACEUTICS (2010)
Rational Design of Immunostimulatory siRNAs
Michael P. Gantier et al.
MOLECULAR THERAPY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy
Alan Richardson et al.
Current Molecular Pharmacology (2010)
Delivery of RNA interference therapeutics using polycation-based nanoparticles
Kenneth Alan Howard
ADVANCED DRUG DELIVERY REVIEWS (2009)
WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth
D. E. Zamora-Avila et al.
CANCER GENE THERAPY (2009)
Toll-like Receptor 9 Activation of Signal Transducer and Activator of Transcription 3 Constrains Its Agonist-Based Immunotherapy
Marcin Kortylewski et al.
CANCER RESEARCH (2009)
Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer
Chi-Mu Chuang et al.
HUMAN GENE THERAPY (2009)
Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: Effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging
Olivia M. Merkel et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Novel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer Cells
Yunching Chen et al.
MOLECULAR PHARMACEUTICS (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Antitumor Vectorized Oligonucleotides in a Model of Ewing Sarcoma: Unexpected Role of Nanoparticles
Hind Elhamess et al.
OLIGONUCLEOTIDES (2009)
Transferrin Receptor Targeted Lipopolyplexes for Delivery of Antisense Oligonucleotide G3139 in a Murine K562 Xenograft Model
Xulang Zhang et al.
PHARMACEUTICAL RESEARCH (2009)
Oligonucleotide decoy to NF-κB slowly released from PLGA microspheres reduces chronic inflammation in rat
Daniela De Stefano et al.
PHARMACOLOGICAL RESEARCH (2009)
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis
Yu-Hung Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
Manuela Aleku et al.
CANCER RESEARCH (2008)
Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
Elizabeth R. Rayburn et al.
DRUG DISCOVERY TODAY (2008)
Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-κB into activated macrophages
Giuseppe De Rosa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts
Takashi Yoshizawa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA
Shyh-Dar Li et al.
MOLECULAR THERAPY (2008)
Chemical Modification of siRNAs for In Vivo Use
Mark A. Behlke
OLIGONUCLEOTIDES (2008)
Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice
H. Hua et al.
CANCER GENE THERAPY (2007)
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
Xulong Zhang et al.
BMC CANCER (2007)
Water-soluble chitosan-based antisense oligodeoxynucleotide of interleukin-5 for treatment of allergic rhinitis
Sung Tae Kim et al.
BIOMATERIALS (2007)
RNA maps reveal new RNA classes and a possible function for pervasive transcription
Philipp Kapranov et al.
SCIENCE (2007)
Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease
Michel Georges et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Interfering with disease: a progress report on siRNA-based therapeutics
Antonin de Fougerolles et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA
Jeremy D. Heidel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Protection of oligonucleotides against enzymatic degradation by pegylated and nonpegylated branched polyethyleneimine
K. Remaut et al.
BIOMACROMOLECULES (2007)
Therapeutic potential for microRNAs
Christine C. Esau et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration
Holger K. de Wolf et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing
Xiudong Liu et al.
BIOMATERIALS (2007)
Discovery and development of anticancer aptamers
Christopher R. Ireson et al.
MOLECULAR CANCER THERAPEUTICS (2006)
A single decoy oligodeoxynucleotides targeting multiple oncoproteins produces strong anticancer effects
Huanhuan Gao et al.
MOLECULAR PHARMACOLOGY (2006)
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells
Shyh-Dar Li et al.
MOLECULAR PHARMACEUTICS (2006)
Oligonucleotide-polyethylenimine complexes targeting retinal cells:: Structural analysis and application to anti-TGFβ-2 therapy
ALG dos Santos et al.
PHARMACEUTICAL RESEARCH (2006)
Exploring the reasons for the large density of triplex-forming oligonucleotide target sequences in the human regulatory regions
JR Goñi et al.
BMC GENOMICS (2006)
Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides
M Glodde et al.
BIOMACROMOLECULES (2006)
Therapeutic potential of Toll-like receptor 9 activation
Arthur M. Krieg
NATURE REVIEWS DRUG DISCOVERY (2006)
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models
CMK Springate et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector
SY Gao et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Enhanced intracellular uptake and inhibition of NF-κB activation by decoy oligonucleotide released from PLGA microspheres
G De Rosa et al.
JOURNAL OF GENE MEDICINE (2005)
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid
SC Semple et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
F Balkwill et al.
CANCER CELL (2005)
A resource for large-scale RNA-interference-based screens in mammals
PJ Paddison et al.
NATURE (2004)
Induction of potent antitumor immunity by in situ targeting of intraturnoral DCs
K Furumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Therapeutic potential of hammerhead ribozymes in the treatment of hyper-proliferative diseases
G Grassi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2004)
Recent improvements in antigene technology
S Buchini et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes
G De Rosa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis
H Cohen-Sacks et al.
GENE THERAPY (2002)
Steric interference modification of the hammerhead ribozyme
KF Blount et al.
CHEMISTRY & BIOLOGY (2002)
Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions
FX Shi et al.
BIOCHEMICAL JOURNAL (2002)
Oblimersen bcl-2 antisense: Facilitating apoptosis in anticancer treatment
RJ Klasa et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
Identification of tissue-specific microRNAs from mouse
M Lagos-Quintana et al.
CURRENT BIOLOGY (2002)
Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes
G De Rosa et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Chitosan: some pharmaceutical and biological aspects - an update
AK Singla et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Polysaccharide colloidal particles as delivery systems for macromolecules
KA Janes et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
SC Semple et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
RNA interference is mediated by 21-and 22-nucleotide RNAs
SM Elbashir et al.
GENES & DEVELOPMENT (2001)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
